NEU4
protein-codingneuraminidase 4, the group of Neuraminidases
Gene summary
The protein encoded by this gene belongs to a family of glycohydrolytic enzymes, which remove terminal sialic acid residues from various sialo derivatives, such as glycoproteins, glycolipids, oligosaccharides, and gangliosides. Alternatively spliced transcript variants encoding different isoforms have been noted for this gene. [provided by RefSeq, Nov 2009]
MANE transcript
Inheritance
ClinVar variants
Top phenotype
gnomAD constraint
Max pathogenic AF
Genomic locus
External References & Databases
Transcript & Mutation Effects
hg38 • Region Span ~8.3 kbGenCC Phenotypes & Disease Associations
Curated gene-disease validity assertions and inheritance patterns
No GenCC data available for this gene.
ClinVar Associated Diseases & Phenotypes
Reported disease conditions connected to NEU4 variants in ClinVar
ClinVar Variants & Pathogenicity by Type
Statistics based on transcript NM_001167600.3. Only rare variants are included.
We include only reliable ClinVar variants with their consequences to MANE Select, MANE Plus Clinical transcripts, or transcripts with TSL equal to 1. Click a count to filter the variants table below.
Slight differences between displayed counts and ClinVar may occur due to a different transcript/consequence chosen by our variant effect predictor, or because we classify Benign/Likely benign as Likely benign and Pathogenic/Likely pathogenic as Likely pathogenic.
| Effect | PathogenicP | Likely pathogenicLP | VUS | Likely benignLB | BenignB | Sum |
|---|---|---|---|---|---|---|
| synonymous | 2 | 2 | ||||
| missense | 129 | 5 | 134 | |||
| nonsense | 0 | |||||
| start loss | 0 | |||||
| frameshift | 0 | |||||
| splice donor/acceptor (+/-2bp) | 0 | |||||
| Total | 0 | 0 | 129 | 7 | 0 | 136 |
Transcript Catalog
Annotated transcript isoforms across RefSeq and Ensembl databases
| Transcript ID | Source | Protein ID | Coding Exons | MANE Status |
|---|---|---|---|---|
| RefSeq | NP_001161072.1 | 3 | MANE Select | |
| Ensembl | ENSP00000385402.1 | 3 | MANE Select | |
| RefSeq | NP_001161071.1 | 4 | Standard | |
| RefSeq | NP_001161073.1 | 3 | Standard |
Gene Ontology (GO) Annotations & Pathways
Biological processes, molecular functions, cellular components and pathways
Pathways ConsensusPathDB
- Other glycan degradation - Homo sapiens (human)
- Sphingolipid metabolism - Homo sapiens (human)
- Metabolism of lipids
- Post-translational protein modification
- Metabolism of proteins
Biological Process
- glycoprotein catabolic process
- glycosphingolipid metabolic process
- ganglioside catabolic process
- oligosaccharide catabolic process
Molecular Function
- exo-alpha-sialidase activity
- protein binding
- exo-alpha-(2->3)-sialidase activity
- exo-alpha-(2->6)-sialidase activity
- exo-alpha-(2->8)-sialidase activity
Cellular Component
- cytoplasm
- lysosome
- membrane
- organelle inner membrane
- lysosomal lumen
gnomAD Constraint
Source:
- Gene type
- protein_coding
- Transcript type
- protein_coding
- Transcript
- ENST00000325935
- Coding exons
- 4
- Length
- 8820
- Individuals with no LoFs
- 125127
- Homozygous LoFs
- 0
- Heterozygous LoFs
- 130
- Defined
- 125257
- p
- 0.000519
| Z-Score | Observed | Expected | Observed/Expected | Mutation Rate | Total Possible | |
|---|---|---|---|---|---|---|
| Missense | -0.162 | 348 | 340 | 1.02 | 0.0000247 | 3093 |
| Missense (PolyPhen) | 137 | 135.48 | 1.0112 | 1267 | ||
| Synonymous | -1.27 | 175 | 155 | 1.13 | 0.0000121 | 1124 |
| Loss of Function | 0.113 | 10 | 10.4 | 0.962 | 5.32e-7 | 103 |
Population LoF Frequency
| Population | CAF | p-value | Status |
|---|---|---|---|
| African | 0.00051 | 0.00043 | rare |
| Latino/Admixed American | 0.00012 | 0.00012 | rare |
| Ashkenazi Jewish | 0.0048 | 0.0048 | notable |
| East Asian | 0 | 0.0 | absent |
| Finnish | 0.00028 | 0.00028 | rare |
| European (Non-Finnish) | 0.00048 | 0.00045 | rare |
| South Asian | 0.00032 | 0.00029 | rare |
| Other | 0.00085 | 0.00082 | rare |
dbNSFP Gene Annotations
Source:
- Function
- FUNCTION: May function in lysosomal catabolism of sialylated glycoconjugates. Has sialidase activity towards synthetic substrates, such as 2'-(4-methylumbelliferyl)-alpha-D-N- acetylneuraminic acid (4-MU-NANA or 4MU-NeuAc). Has a broad substrate specificity being active on glycoproteins, oligosaccharides and sialylated glycolipids. {ECO:0000269|PubMed:14962670, ECO:0000269|PubMed:15213228}.;
Recessive Scores
- pRec
- 0.222
Essentials
- Essential (CRISPR)
- N
- Essential (CRISPR2)
- N
- Essential (gene trap)
- N
- Indispensability pred.
- E
- Indispensability score
- 0.986
Gene Damage Prediction
| All | Recessive | Dominant | |
|---|---|---|---|
| Mendelian | Medium | Medium | Medium |
| Primary Immunodeficiency | Medium | Medium | Medium |
| Cancer | Medium | Medium | Medium |